Two researchers from the Icahn School of Medicine at Mount Sinai recently published their critical evaluation of a new brain ...

Anyone with any experience as an investor knows that while penny stocks can produce strong returns, they’re also risky. You ...

Lead program TG4050 (individualized immunotherapy): – First signs of clinical benefit in adjuvant head and neck ... 2024 compared to €4.8 million for the same period in 2023. The research tax credit ...

Clinical research will offer insight for specific targeting of active pharmaceutical ingredients (API) that will further support Phase 1 Human ...

Researchers from Deakin University reveal how yoyo dieting disrupts gut health, leading to weight regain and obesity-related ...

Despite this, there is a paucity of research examining the impact of these ... multi-phase explanatory study (REB 2023-8964) ...

The latest study should be a comfort for caffeine drinkers, but isn't necessarily a sign to start a new habit.

Mahableshwarkar M.D., DLFAPA, Senior Vice President, Clinical Development ... decades of pharmaceutical industry experience in new drug development across all phases of research (pre-IND to ...

According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Increased funding and new public health policies for sickle cell research are needed to ease the burden on low-income nations ...